ESPI/EBI - komunikaty giełdowe

Dissimination of monthly sales information

Individual financial report according to IFRS as at 31 December 2022

"Sopharma" AD submitted for approval to the Financial Supervision Commission for an Agreement for conversion by merger of the subsidiary company "Biopharm-engineering" AD

Publication of the Tender offering addressed to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD and Opinion of the Board of Directors in connection with Art. 154 of the Law on Public Offering of Securities and Art. 36 of Ordinance 13 of 22.12.2003 on tender offerings for purchase and exchange of shares

Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD

Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 11 January 2023.

Sales revenues for December 2022

Notification from Ivan Badinski under Art. 19 of Regulation (EU) No 596/2014 of 12 December 2022.

Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2022.

Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.